Unity Biotechnology, Inc.
NASDAQ:UBX
1.26 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 19.803 | 12.736 | 32.905 | 17.807 | 37.473 | 15.399 | 7.298 | 89.286 |
| Short Term Investments
| 23.398 | 82.059 | 55.17 | 79.892 | 90.015 | 155.736 | 79.212 | 0 |
| Cash and Short Term Investments
| 43.201 | 94.795 | 88.075 | 97.699 | 127.488 | 171.135 | 86.51 | 89.286 |
| Net Receivables
| 1.577 | 0.235 | 0 | 0 | 0 | 0 | 1.382 | 0 |
| Inventory
| 0 | -0.235 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.827 | 1.74 | 1.879 | 3.167 | 1.999 | 1.83 | 0.988 | 4.123 |
| Total Current Assets
| 46.605 | 96.535 | 90.504 | 100.866 | 129.487 | 172.965 | 88.88 | 93.409 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 18.063 | 26.867 | 31.228 | 36.136 | 16.636 | 6.238 | 6.958 | 2.248 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.896 | 0.896 | 1.993 | 17.871 | 3.025 | 1.151 | 5.118 | 0.652 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.126 | 0.052 | 0.987 | 1.446 | 2.073 | 1.021 | 1.068 | 0.339 |
| Total Non-Current Assets
| 19.085 | 27.815 | 34.208 | 55.453 | 21.734 | 8.41 | 13.144 | 3.239 |
| Total Assets
| 65.69 | 124.35 | 124.712 | 156.319 | 151.221 | 181.375 | 102.024 | 96.648 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1.38 | 1.79 | 1.985 | 2.558 | 5.185 | 4.847 | 2.378 | 0.964 |
| Short Term Debt
| 3.451 | 9.476 | 3.055 | 4.52 | 0.045 | 0.078 | 0.078 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0.216 | 7.364 | -0.045 | -0.078 | -0.078 | 0 |
| Other Current Liabilities
| 3.009 | 8.354 | 11.361 | 0.021 | 12.031 | 11.735 | 5.519 | 2.727 |
| Total Current Liabilities
| 7.84 | 19.62 | 16.617 | 14.463 | 17.216 | 16.582 | 7.897 | 3.691 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 23.539 | 37.882 | 48.503 | 58.976 | 0 | 0.045 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.913 | 0 | 0.023 | 0 | 13.298 | 4.055 | 3.284 | 134.493 |
| Total Non-Current Liabilities
| 29.452 | 37.882 | 48.526 | 58.976 | 13.298 | 4.1 | 3.284 | 134.493 |
| Total Liabilities
| 37.292 | 57.502 | 65.143 | 73.439 | 30.514 | 20.682 | 11.181 | 138.184 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 181.375 | 173.956 | 131.089 |
| Common Stock
| 0.002 | 0.001 | 0.006 | 0.005 | 0.005 | 0.004 | 0.003 | 0.001 |
| Retained Earnings
| -484.353 | -459.951 | -400.024 | -339.299 | -245.455 | -163.278 | -86.88 | -42.224 |
| Accumulated Other Comprehensive Income/Loss
| -0.024 | -0.251 | -0.044 | 0.005 | 0.09 | -0.095 | -0.104 | -0.202 |
| Other Total Stockholders Equity
| 512.773 | 527.049 | 459.631 | 422.169 | 366.067 | 142.687 | 3.868 | -130.2 |
| Total Shareholders Equity
| 28.398 | 66.848 | 59.569 | 82.88 | 120.707 | 160.693 | 90.843 | -41.536 |
| Total Equity
| 28.398 | 66.848 | 59.569 | 82.88 | 120.707 | 160.693 | 90.843 | -41.536 |
| Total Liabilities & Shareholders Equity
| 65.69 | 124.35 | 124.712 | 156.319 | 151.221 | 181.375 | 102.024 | 96.648 |